KTTA

PASITHEA THERAPEUTICS CORP

KTTA·70261F202·US·Common Stock·Healthcare - Biotechnology-13D/G

KTTA (PASITHEA THERAPEUTICS CORP) is held by 12 institutional investors as of Q1 2026. Largest holders: Janus Henderson Group Ltd. ($1.6M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($1.6M), AMERIPRISE FINANCIAL INC ($1M). Net institutional sentiment: Mixed.

12
Holders
Avg rating(1 Elite)
$4.4M
Total Value
46% (16)
Fund Consensus
6 buying - 7 selling
KTTASmart Money Verdict
View all
Held by 12 funds
1 elite
Who's Trading
ActivistCOCoastlands Capital LP11.5%Jul 1, 2026
ActivistSTStonepine Capital Management, LLC5.8%Jun 23, 2026
InsiderCLCoastlands Capital LPBuy $53KJun 17, 2026
ActivistAmeriprise Financial, Inc.Ameriprise Financial, Inc.5.4%May 15, 2026
ActivistFUFunicular Funds, LP7.4%Apr 22, 2026
ActivistOPOpaleye Management Inc.10.0%Apr 8, 2026
ActivistCOCoastlands Capital LP10.0%Feb 27, 2026
InsiderSLSTEINMAN LAWRENCEBuy $100KNov 28, 2025
InsiderMTMarques TiagoBuy $25KNov 28, 2025
InsiderDSDumesnil SimonBuy $25KNov 28, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
2.1M$1.6M0.0%-57.39%
0
Unchanged
2.1M$1.6M0.0%-57.39%
0
Decreased
1.4M(-30.0%)$1M0.0%-57.39%
0
Increased
103,985(+90.8%)$77,1380.0%-44.20%
23
New
93,399$69,2830.0%-38.75%
29
New
53,815$39,9310.0%-38.75%
31
New
43,860$32,5440.0%-38.75%
30
Increased
33,751(+62.4%)$25,0360.0%-34.73%
28
Increased
26,149(+97.2%)$19,4020.0%-49.89%
20
Decreased
21,054(-56.8%)$15,6180.0%-41.30%
0
Decreased
19,372(-31.0%)$14,3700.0%-57.39%
0
Unchanged
150$1070.0%-83.39%
0
Exited
0(-100.0%)$00.0%-72.88%
0
Exited
0(-100.0%)$72,4760.0%+6.98%
0
Exited
0(-100.0%)$76,5900.0%-17.40%
0
Exited
0(-100.0%)$810.0%-23.89%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used